These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial. Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY. Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299 [Abstract] [Full Text] [Related]
5. The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam. Maertens K, Hoang TT, Nguyen TD, Caboré RN, Duong TH, Huygen K, Hens N, Van Damme P, Dang DA, Leuridan E. Clin Infect Dis; 2016 Dec 01; 63(suppl 4):S197-S204. PubMed ID: 27838673 [Abstract] [Full Text] [Related]
6. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, Burbidge P, Thalasselis V, Hallis B, Goldblatt D, Borrow R, Heath PT, Miller E. Clin Infect Dis; 2015 Dec 01; 61(11):1637-44. PubMed ID: 26374816 [Abstract] [Full Text] [Related]
7. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age. Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O. Hum Vaccin Immunother; 2014 Dec 01; 10(10):2795-8. PubMed ID: 25483640 [Abstract] [Full Text] [Related]
8. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa). Dhillon S. BioDrugs; 2010 Oct 01; 24(5):299-302. PubMed ID: 20795752 [Abstract] [Full Text] [Related]
15. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. Pediatrics; 1997 Nov 01; 100(5):772-88. PubMed ID: 9346976 [Abstract] [Full Text] [Related]
17. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers. Wanlapakorn N, Maertens K, Thongmee T, Srimuan D, Thatsanathorn T, Van Damme P, Leuridan E, Poovorawan Y. Vaccine; 2020 Oct 14; 38(44):6914-6921. PubMed ID: 32888740 [Abstract] [Full Text] [Related]
18. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine. Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E. Int J Infect Dis; 2007 Nov 14; 11(6):488-95. PubMed ID: 17349809 [Abstract] [Full Text] [Related]
19. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women. Huygen K, Caboré RN, Maertens K, Van Damme P, Leuridan E. Vaccine; 2015 Aug 07; 33(33):4117-23. PubMed ID: 26187257 [Abstract] [Full Text] [Related]
20. An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England. Sapuan S, Andrews N, Hallis B, Hole L, Jones CE, Matheson M, Miller E, Snape MD, Heath PT. Vaccine; 2022 Nov 22; 40(49):7050-7056. PubMed ID: 36272877 [Abstract] [Full Text] [Related] Page: [Next] [New Search]